How Much Does Low-Dose Naltrexone Cost in Ohio in 2026?

Ohio LDN Pricing: What You Will Actually Pay in 2026

The average cash-pay price for low-dose naltrexone across Ohio compounding pharmacies in 2026 sits at roughly $50 per month for a standard 4.5 mg oral capsule taken once nightly. That figure holds whether you fill through a local 503A compounding pharmacy in Columbus, Cleveland, or Cincinnati, or use an out-of-state 503A pharmacy that ships to Ohio addresses.

This $50 monthly cost is specific to the compounded formulation. The FDA-approved 50 mg naltrexone tablet (brand name ReVia) carries a different price point entirely, often ranging from $25 to $90 per month at retail pharmacies depending on the manufacturer and pharmacy markup. But 50 mg tablets cannot simply be split down to LDN doses of 1.5 mg to 4.5 mg with clinical precision. Compounding is necessary because no FDA-approved product exists at LDN dose ranges 1. A pilot trial by Younger et al. (2009, N=10) demonstrated that naltrexone at 4.5 mg/day reduced fibromyalgia symptoms by 30% compared to placebo, establishing the dose range that compounding pharmacies now prepare 1.

Price variation across Ohio is minimal. Unlike branded pharmaceuticals where retail markup differs significantly between independent pharmacies and large chains, compounded LDN pricing is driven by bulk naltrexone powder cost, capsule preparation labor, and pharmacy overhead. Most 503A pharmacies in Ohio price a 30-day supply between $40 and $60.

Why Ohio Medicaid Does Not Cover LDN

Ohio Medicaid does not cover low-dose naltrexone for off-label uses including fibromyalgia, Crohn's disease, multiple sclerosis, or other autoimmune and inflammatory conditions. Coverage for naltrexone under Ohio Medicaid is restricted to its FDA-approved indications: opioid use disorder and alcohol dependence, both at the 50 mg dose 2.

The distinction matters. The FDA approved naltrexone in 1984 as a 50 mg oral tablet for blocking opioid receptors in addiction treatment 2. LDN, at doses roughly 1/10th the approved amount, operates through a different proposed mechanism: brief opioid receptor blockade that triggers a rebound increase in endogenous endorphin and enkephalin production, along with modulation of toll-like receptor 4 (TLR4) on microglia 3. Because LDN has never gone through a separate FDA approval process for these off-label indications, state Medicaid formularies almost universally exclude it.

Ohio Medicaid beneficiaries who want LDN have limited options. Prior authorization requests for off-label naltrexone are routinely denied. The most practical path is paying the $50 monthly cash price directly to a compounding pharmacy, bypassing the Medicaid formulary entirely. Some prescribers have reported success obtaining coverage under type 2 diabetes codes in specific managed care organizations, but this is inconsistent and should not be relied upon.

Compounded LDN Legality in Ohio: 503A Pharmacy Rules

Compounded low-dose naltrexone is fully legal in Ohio when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Ohio follows federal compounding law established under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits licensed pharmacies to compound medications for individual patients based on a prescriber's order 4.

A 503A pharmacy compounds each prescription individually. This is different from a 503B outsourcing facility, which can produce compounded drugs in larger batches without patient-specific prescriptions. Both pathways are legal in Ohio, but most LDN patients obtain their medication through 503A pharmacies because the per-unit cost is lower for small-volume prescriptions and local availability is broad.

Ohio has over 200 licensed compounding pharmacies according to the Ohio Board of Pharmacy. Not all compound naltrexone, so patients should confirm LDN availability before transferring a prescription. Key questions to ask any Ohio compounding pharmacy: Do you use USP 795-compliant processes for non-sterile compounding? What is your source for bulk naltrexone hydrochloride powder? Do you perform potency testing on finished capsules? Reputable pharmacies will answer all three without hesitation.

Ohio residents can also legally receive compounded LDN shipped from out-of-state 503A pharmacies, provided the pharmacy holds appropriate licenses. Several national telehealth-plus-pharmacy platforms now serve Ohio and bundle the prescriber consultation with pharmacy fulfillment for a combined monthly price near $50 to $75.

Telehealth LDN Prescriptions in Ohio

Ohio permits telehealth prescribing of low-dose naltrexone with no in-person visit requirement for non-controlled substances. Naltrexone is not a controlled substance under either federal or Ohio law, which means prescribers can evaluate patients, write the prescription, and transmit it to a compounding pharmacy entirely through a video or audio telehealth encounter 5.

This is significant for patients in rural Ohio counties. Access to physicians familiar with LDN prescribing can be limited outside metropolitan areas. A 2018 survey published in Pain Medicine found that fewer than 15% of primary care physicians had prescribed LDN, and awareness was concentrated among integrative and functional medicine practitioners 6. Telehealth removes the geographic constraint.

Several telehealth platforms now operate in Ohio with LDN-specific consultation pathways. Typical workflow: complete an intake questionnaire, attend a 15- to 20-minute video consultation with a licensed prescriber, receive a prescription sent directly to a partner compounding pharmacy, and have the medication shipped to your Ohio address. Total cost for the consultation plus a 30-day supply generally falls between $50 and $99 depending on the platform and whether follow-up visits are bundled.

Ohio's telehealth parity law (Ohio Rev. Code § 3902.30) requires commercial insurers to cover telehealth visits at the same rate as in-person visits. The consultation itself may be covered even when the LDN prescription is not. Patients should verify telehealth visit coverage with their specific plan before scheduling.

Commercial Insurance Coverage for LDN in Ohio

Most commercial insurance plans in Ohio do not cover compounded low-dose naltrexone. The reasons mirror the Medicaid exclusion: LDN is off-label, compounded, and lacks a dedicated NDA or ANDA filing with the FDA. Insurance pharmacy benefit managers (PBMs) including Express Scripts, CVS Caremark, and OptumRx generally exclude compounded medications from standard formularies unless a specific plan rider includes compounding coverage.

There are exceptions. Some self-insured employer plans in Ohio have broader compounding benefits. Patients with these plans may submit claims for reimbursement after paying cash at the pharmacy. The success rate varies. Even when compounding is nominally covered, the off-label status of LDN gives PBMs grounds for denial.

A practical strategy: ask your prescriber to submit a prior authorization with supporting literature. The Younger et al. pilot data 1, the Stanford fibromyalgia trial (Younger et al., 2013, N=31, showing 28.8% reduction in pain scores) 7, and a systematic review by Patten et al. (2018) covering multiple sclerosis, Crohn's disease, and fibromyalgia applications 6 provide the strongest published evidence. Prior authorizations succeed in perhaps 5% to 10% of attempts for off-label compounded drugs, but the downside risk is only the time spent submitting.

Dr. Jarred Younger, the researcher behind multiple LDN trials at the University of Alabama at Birmingham, has stated: "Low-dose naltrexone has a favorable safety profile and a cost that makes it accessible even without insurance coverage. The barrier is not price but physician awareness" 1.

Finding the Cheapest LDN in Ohio

The most affordable path to low-dose naltrexone in Ohio is a direct cash-pay arrangement with a 503A compounding pharmacy, either local or mail-order. At $50 per month, LDN is already among the least expensive prescription therapies for chronic pain and autoimmune conditions.

Here are specific strategies Ohio patients use to reduce costs further:

90-day supply discounts. Many compounding pharmacies offer a 10% to 15% discount for 90-day fills. A 90-day supply at $135 (vs. $150 for three separate monthly fills) saves $60 annually. Small savings, but they compound over years of use.

Telehealth bundle pricing. Several platforms bundle the prescriber visit and pharmacy fulfillment. When the consultation fee is included in the monthly price rather than billed separately, total out-of-pocket cost drops compared to paying a $75 to $150 office visit plus a separate pharmacy charge.

Compounding pharmacy price comparison. Call at least three Ohio compounding pharmacies before filling. Prices for a 30-day supply of 4.5 mg LDN capsules range from $35 to $65 across the state. The lowest prices tend to come from pharmacies that compound high volumes of LDN and have optimized their workflow for this specific preparation.

HSA and FSA eligibility. LDN purchased with a valid prescription qualifies as an eligible expense under Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA). Paying with pre-tax dollars effectively reduces cost by 22% to 37% depending on your marginal tax rate.

The Endocrine Society's 2023 clinical practice guidelines on obesity pharmacotherapy acknowledged the growing interest in repurposed medications including naltrexone combinations, noting that "cost-effectiveness analysis should account for off-label pricing when branded alternatives exceed $1,000 monthly" 8.

LDN Dosing and What to Expect

Standard LDN dosing starts at 1.5 mg nightly for the first two weeks, then increases to 3.0 mg for two weeks, and reaches the target dose of 4.5 mg by week five. This slow titration reduces the most common side effect: vivid dreams, reported in approximately 37% of patients during the first week of therapy in the Younger fibromyalgia trial 7.

Other reported side effects are mild. Headache occurs in about 15% of patients, and transient nausea in roughly 10%, both typically resolving within the first two weeks 1. Serious adverse events at LDN doses have not been reported in published clinical trials, though the total number of randomized participants across all published LDN studies remains under 1,000.

Patients taking opioid medications cannot use LDN. Even at 4.5 mg, naltrexone retains enough opioid receptor affinity to precipitate withdrawal in opioid-dependent individuals 5. A minimum 7- to 10-day opioid washout period is required before starting LDN, and some practitioners recommend 14 days for long-acting opioids like methadone.

LDN is taken at bedtime because the brief receptor blockade (approximately 4 to 6 hours at this dose) is thought to trigger endorphin upregulation during sleep. Taking LDN in the morning may cause daytime fatigue and is generally not recommended.

The LDN Research Trust, a UK-based patient advocacy organization, maintains a registry of over 15,000 self-reported LDN users. Their 2023 survey data showed 65% of respondents reporting meaningful symptom improvement, with fibromyalgia and Hashimoto's thyroiditis showing the highest self-reported response rates 9.

Ohio-Specific Pharmacy and Regulatory Considerations

The Ohio Board of Pharmacy regulates all compounding activity within the state under Ohio Administrative Code Chapter 4729. Pharmacies must comply with USP 795 standards for non-sterile compounding, which covers LDN capsule preparation 4.

Ohio does not impose additional state-level restrictions on naltrexone compounding beyond federal 503A requirements. Some states have added extra documentation or reporting requirements for compounded controlled substances, but naltrexone is not scheduled, so these provisions do not apply.

One regulatory nuance: Ohio permits pharmacists to compound "reasonable quantities" in anticipation of prescription orders under 503A, meaning your pharmacy may have LDN capsules ready for same-day or next-day pickup rather than requiring a multi-day preparation window. This is a practical convenience, not a guarantee. Ask your pharmacy about typical turnaround time.

For patients considering out-of-state mail-order compounding pharmacies, Ohio requires that the shipping pharmacy hold a non-resident pharmacy license issued by the Ohio Board of Pharmacy. Reputable national compounding pharmacies already maintain these licenses, but patients should verify before placing an order.

Dr. Norman Shealy, a neurosurgeon and early LDN researcher, noted: "The pharmacoeconomic case for low-dose naltrexone is compelling. A $50 monthly therapy that may reduce the need for biologics costing $3,000 to $7,000 monthly deserves rigorous phase III evaluation" 3.